Exact Mass: 166.0486

Exact Mass Matches: 166.0486

Found 88 metabolites which its exact mass value is equals to given mass value 166.0486, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

1-Methylxanthine

2-hydroxy-1-methyl-6,9-dihydro-1H-purin-6-one

C6H6N4O2 (166.0491)


1-Methylxanthine is one of the major metabolites of caffeine in humans. The oxidation of 1-methylxanthine to 1-methyluric acid occurs so rapidly that the parent compound could not be detected in plasma, and only low concentrations could be detected in the brain (PMID: 28863020). 1-methylxanthine is the major metabolites of caffeine in the human. The oxidation of 1-methylxanthine to 1-methyluric acid occurred so rapidly that the parent compound could not be detected in plasma, and only low concentrations could be detected in brain. (PMID: 28863020 [HMDB] 1-Methylxanthine, a caffeine derivative, is an essential human urinary metabolite of caffeine and theophylline (1,3-dimethylxanthine, TP)[1]. 1-Methylxanthine enhances the radiosensitivity of tumor cells[2]. 1-Methylxanthine, a caffeine derivative, is an essential human urinary metabolite of caffeine and theophylline (1,3-dimethylxanthine, TP)[1]. 1-Methylxanthine enhances the radiosensitivity of tumor cells[2].

   

3-Methylxanthine

3-methyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione

C6H6N4O2 (166.0491)


3-methyl-9H-xanthine is a 3-methylxanthine tautomer where the imidazole proton is located at the 9-position. It has a role as a metabolite. It is a tautomer of a 3-methyl-7H-xanthine. 3-Methylxanthine, also known as 3 MX or purine analog, belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. 3-Methylxanthine is a caffeine and a theophylline metabolite. (PMID 16870158, 16678550) 3-Methylxanthine. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=1076-22-8 (retrieved 2024-07-02) (CAS RN: 1076-22-8). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). 3-Methylxanthine, a xanthine derivative, is a cyclic guanosine monophosphate (GMP) inhibitor, with an IC50 of 920 μM on guinea-pig isolated trachealis muscle. 3-Methylxanthine, a xanthine derivative, is a cyclic guanosine monophosphate (GMP) inhibitor, with an IC50 of 920 μM on guinea-pig isolated trachealis muscle.

   

D-Xylonic acid

(2R,3S,4R)-2,3,4,5-tetrahydroxypentanoic acid

C5H10O6 (166.0477)


D-​Xylonic acid belongs to the family of hydroxy fatty acids. These are fatty acids in which the chain bears an hydroxyl group. ​D-​Xylonic acid has been identified in the human placenta (PMID: 32033212).

   

Arabonate/xylonate

(2S,3R,4R)-2,3,4,5-tetrahydroxypentanoic acid

C5H10O6 (166.0477)


Arabinonic acid (CAS: 13752-83-5) is a substrate of L-arabinonate dehydratase [EC 4.2.1.25] in the pathway ascorbate and aldarate metabolism (KEGG). Arabinonic acid is a substrate of L-arabinonate dehydratase [EC 4.2.1.25] in pathway ascorbate and aldarate metabolism. (KEGG) [HMDB]

   

Ribonic acid

(2R,3R,4R)-2,3,4,5-tetrahydroxypentanoic acid

C5H10O6 (166.0477)


Ribonic acid (CAS: 17812-24-7) is a product of the enzyme ribose 1-dehydrogenase (NADP+) [EC 1.1.1.115] (KEGG). Ribonic acid is a product of the enzyme ribose 1-dehydrogenase (NADP+) [EC 1.1.1.115] (KEGG). [HMDB]

   

7-Methylxanthine

7-methyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione

C6H6N4O2 (166.0491)


7-Methylxanthine is a methyl derivative of xanthine, found occasionally in human urine. 7-Methylxanthine is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites, including 7-methylxanthine. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis. Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. (PMID:11712316, 15833286, 3506820, 15013152). Found in sugar cane and other biol. sources, a urinary metabolite of caffeine in man 7-Methylxanthine. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=552-62-5 (retrieved 2024-07-16) (CAS RN: 552-62-5). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). 7-Methylxanthine, a methyl derivative of xanthine, is one of the purine components in urinary calculi.

   

L-Lyxonic acid

(2R,3R,4S)-2,3,4,5-tetrahydroxypentanoic acid

C5H10O6 (166.0477)


L-​Lyxonic acid belongs to the family of sugar acids and derivatives. These are compounds containing a saccharide unit which bears a carboxylic acid group.

   

L-Xylonic acid

(2S,3R,4S)-2,3,4,5-tetrahydroxypentanoic acid

C5H10O6 (166.0477)


L-Xylonic acid belongs to the family of sugar acids and derivatives. These are compounds containing a saccharide unit which bears a carboxylic acid group.

   

L-Arabinonate

2R,3S,4S,5-tetraydroxy-pentanoic acid

C5H10O6 (166.0477)


   

D-apionate

D-apionate

C5H10O6 (166.0477)


   

S-Propyl 1-propanesulfinothioate

1-Propanesulphinothioic acid, S-propyl ester

C6H14OS2 (166.0486)


S-Propyl 1-propanesulfinothioate is found in onion-family vegetables. S-Propyl 1-propanesulfinothioate is isolated from onions, garlic and other allium Isolated from onions, garlic and other alliums. S-Propyl 1-propanesulfinothioate is found in onion-family vegetables.

   

9-Methylxanthine

9-methyl-2,3,6,9-tetrahydro-1H-purine-2,6-dione

C6H6N4O2 (166.0491)


9-Methylxanthine is a diuretic agent that serves as a smooth muscle relexant and cardiac muscle and CNS stimulant. Clinically, it is employed as a bronchodilator. 9-Methylxanthine is found to be effective in treating apnea in preterm infants (PMID: 11686952). In another study, 9-Methylxanthine, as a chemical relatives of caffeine, is able to evoke contractures in mammalian heart. (PMID: 1226453)

   

Xylan

(2R,3R,5S,6S)-tetrahydropyran-2,3,4,5,6-pentol

C5H10O6 (166.0477)


Xylan is a group of hemicelluloses, representing the third most abundant biopolymer on Earth. It is found in plants, in the secondary cell walls of dicotyledonous plants and in all cell walls of grasses (monocotyledonous). Xylans are polysaccharides made up of β-1,4-linked xylose (a pentose sugar) residues with side branches of α-arabinofuranose and α-glucuronic acids and contribute to cross-linking of cellulose microfibrils and lignin through ferulic acid residues. On the basis of the substituting groups, xylan can be categorized into three classes i) glucuronoxylan (GX) ii) neutral arabinoxylan (AX) and iii) glucuronoarabinoxylan (GAX). The quality of cereal flours and the hardness of dough are largely affected by the amount of xylan. Xylan is one of the foremost anti-nutritional factors in commonly used feedstuff raw materials. It is a major component of plant secondary cell walls which is a major source of renewable energy especially for second generation biofuels. However, since microorganisms like yeast cannot ferment pentoses naturally, xylose (the pentose backbone of xylan) results hard to ferment in biofuel production, reducing its use in renewable energy production (PMID: 18299887, PMID: 31077637). Occurs in all land plants, component of dietary roughage

   

D-Xylonic acid

D-Arabonic acid

C5H10O6 (166.0477)


   

7-methyl-7,9-dihydro-1H-purine-6,8-dione

7-methyl-7,9-dihydro-1H-purine-6,8-dione

C6H6N4O2 (166.0491)


   

9-methyl-7,9-dihydro-1H-purine-6,8-dione

9-methyl-7,9-dihydro-1H-purine-6,8-dione

C6H6N4O2 (166.0491)


   

1-Me-6,8-Purinediol

1-Me-6,8-Purinediol

C6H6N4O2 (166.0491)


   

3-methyl-7,9-dihydro-3H-purine-6,8-dione

3-methyl-7,9-dihydro-3H-purine-6,8-dione

C6H6N4O2 (166.0491)


   

SCHEMBL12017370

SCHEMBL12017370

C5H10O6 (166.0477)


   

3-Methylxanthine

3-Methylxanthine

C6H6N4O2 (166.0491)


MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; GMSNIKWWOQHZGF-UHFFFAOYSA-N_STSL_0034_3-Methylxanthine_0500fmol_180410_S2_LC02_MS02_57; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. 3-Methylxanthine, a xanthine derivative, is a cyclic guanosine monophosphate (GMP) inhibitor, with an IC50 of 920 μM on guinea-pig isolated trachealis muscle. 3-Methylxanthine, a xanthine derivative, is a cyclic guanosine monophosphate (GMP) inhibitor, with an IC50 of 920 μM on guinea-pig isolated trachealis muscle.

   

7-Methylxanthine

7-Methylxanthine

C6H6N4O2 (166.0491)


An oxopurine that is xanthine in which the hydrogen attached to the nitrogen at position 7 is replaced by a methyl group. It is an intermediate metabolite in the synthesis of caffeine. 7-Methylxanthine, a methyl derivative of xanthine, is one of the purine components in urinary calculi.

   

1-Methylxanthine

1-Methylxanthine

C6H6N4O2 (166.0491)


MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; MVOYJPOZRLFTCP-UHFFFAOYSA-N_STSL_0033_1-Methylxanthine_0500fmol_180410_S2_LC02_MS02_41; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. 1-Methylxanthine, a caffeine derivative, is an essential human urinary metabolite of caffeine and theophylline (1,3-dimethylxanthine, TP)[1]. 1-Methylxanthine enhances the radiosensitivity of tumor cells[2]. 1-Methylxanthine, a caffeine derivative, is an essential human urinary metabolite of caffeine and theophylline (1,3-dimethylxanthine, TP)[1]. 1-Methylxanthine enhances the radiosensitivity of tumor cells[2].

   

Allicin + 4H (not validated)

Allicin + 4H (not validated)

C6H14OS2 (166.0486)


Annotation level-3

   

1-Methylxanthine; LC-tDDA; CE10

1-Methylxanthine; LC-tDDA; CE10

C6H6N4O2 (166.0491)


   

1-Methylxanthine; LC-tDDA; CE20

1-Methylxanthine; LC-tDDA; CE20

C6H6N4O2 (166.0491)


   

1-Methylxanthine; LC-tDDA; CE30

1-Methylxanthine; LC-tDDA; CE30

C6H6N4O2 (166.0491)


   

1-Methylxanthine; LC-tDDA; CE40

1-Methylxanthine; LC-tDDA; CE40

C6H6N4O2 (166.0491)


   

3-Methylxanthine; LC-tDDA; CE10

3-Methylxanthine; LC-tDDA; CE10

C6H6N4O2 (166.0491)


   

3-Methylxanthine; LC-tDDA; CE20

3-Methylxanthine; LC-tDDA; CE20

C6H6N4O2 (166.0491)


   

3-Methylxanthine; LC-tDDA; CE30

3-Methylxanthine; LC-tDDA; CE30

C6H6N4O2 (166.0491)


   

3-Methylxanthine; LC-tDDA; CE40

3-Methylxanthine; LC-tDDA; CE40

C6H6N4O2 (166.0491)


   

9-Methylxanthine; LC-tDDA; CE10

9-Methylxanthine; LC-tDDA; CE10

C6H6N4O2 (166.0491)


   

9-Methylxanthine; LC-tDDA; CE20

9-Methylxanthine; LC-tDDA; CE20

C6H6N4O2 (166.0491)


   

9-Methylxanthine; LC-tDDA; CE30

9-Methylxanthine; LC-tDDA; CE30

C6H6N4O2 (166.0491)


   

9-Methylxanthine; LC-tDDA; CE40

9-Methylxanthine; LC-tDDA; CE40

C6H6N4O2 (166.0491)


   

7-Methylxanthine; LC-tDDA; CE10

7-Methylxanthine; LC-tDDA; CE10

C6H6N4O2 (166.0491)


   

7-Methylxanthine; LC-tDDA; CE20

7-Methylxanthine; LC-tDDA; CE20

C6H6N4O2 (166.0491)


   

7-Methylxanthine; LC-tDDA; CE30

7-Methylxanthine; LC-tDDA; CE30

C6H6N4O2 (166.0491)


   

7-Methylxanthine; LC-tDDA; CE40

7-Methylxanthine; LC-tDDA; CE40

C6H6N4O2 (166.0491)


   

9-Methylxanthine; AIF; CE0; CorrDec

9-Methylxanthine; AIF; CE0; CorrDec

C6H6N4O2 (166.0491)


   

9-Methylxanthine; AIF; CE10; CorrDec

9-Methylxanthine; AIF; CE10; CorrDec

C6H6N4O2 (166.0491)


   

9-Methylxanthine; AIF; CE30; CorrDec

9-Methylxanthine; AIF; CE30; CorrDec

C6H6N4O2 (166.0491)


   

9-Methylxanthine; AIF; CE0; MS2Dec

9-Methylxanthine; AIF; CE0; MS2Dec

C6H6N4O2 (166.0491)


   

9-Methylxanthine; AIF; CE10; MS2Dec

9-Methylxanthine; AIF; CE10; MS2Dec

C6H6N4O2 (166.0491)


   

9-Methylxanthine; AIF; CE30; MS2Dec

9-Methylxanthine; AIF; CE30; MS2Dec

C6H6N4O2 (166.0491)


   

7-Methylxanthine; AIF; CE0; CorrDec

7-Methylxanthine; AIF; CE0; CorrDec

C6H6N4O2 (166.0491)


   

7-Methylxanthine; AIF; CE10; CorrDec

7-Methylxanthine; AIF; CE10; CorrDec

C6H6N4O2 (166.0491)


   

7-Methylxanthine; AIF; CE30; CorrDec

7-Methylxanthine; AIF; CE30; CorrDec

C6H6N4O2 (166.0491)


   

7-Methylxanthine; AIF; CE0; MS2Dec

7-Methylxanthine; AIF; CE0; MS2Dec

C6H6N4O2 (166.0491)


   

7-Methylxanthine; AIF; CE10; MS2Dec

7-Methylxanthine; AIF; CE10; MS2Dec

C6H6N4O2 (166.0491)


   

7-Methylxanthine; AIF; CE30; MS2Dec

7-Methylxanthine; AIF; CE30; MS2Dec

C6H6N4O2 (166.0491)


   

Apionic acid

2,3,4,4-tetrahydroxy-pentanoic acid

C5H10O6 (166.0477)


   

O-Benzoylthiamine

1-Propanesulfinothioic acid, S-propyl ester

C6H14OS2 (166.0486)


   

9-Methylxanthine

9-methyl-2,3,6,9-tetrahydro-1H-purine-2,6-dione

C6H6N4O2 (166.0491)


   

1H-Imidazole-5-carboxylicacid,2-amino-4-cyano-1-methyl-(9CI)

1H-Imidazole-5-carboxylicacid,2-amino-4-cyano-1-methyl-(9CI)

C6H6N4O2 (166.0491)


   

1H-Imidazole-4-carboxylicacid,2-amino-5-cyano-1-methyl-(9CI)

1H-Imidazole-4-carboxylicacid,2-amino-5-cyano-1-methyl-(9CI)

C6H6N4O2 (166.0491)


   

1H-Imidazole-4-carboxylicacid,2-amino-5-cyano-,methylester(9CI)

1H-Imidazole-4-carboxylicacid,2-amino-5-cyano-,methylester(9CI)

C6H6N4O2 (166.0491)


   

pyrazine-2,5-dicarboxamide

pyrazine-2,5-dicarboxamide

C6H6N4O2 (166.0491)


   

2-methoxy-1,3-bis(methylsulfanyl)propane

2-methoxy-1,3-bis(methylsulfanyl)propane

C6H14OS2 (166.0486)


   

L-Ribonic acid

L-(+)-Ribonic acid

C5H10O6 (166.0477)


A ribonic acid having L-configuration.

   

2,3-pyrazinedicarboxamide

2,3-pyrazinedicarboxamide

C6H6N4O2 (166.0491)


   

1H-Imidazo[1,2-b]pyrazole-6-carboxylicacid,7-amino-(9CI)

1H-Imidazo[1,2-b]pyrazole-6-carboxylicacid,7-amino-(9CI)

C6H6N4O2 (166.0491)


   

1H-Purine-2,6-dione,3,9-dihydro-8-methyl-

1H-Purine-2,6-dione,3,9-dihydro-8-methyl-

C6H6N4O2 (166.0491)


   

6-Methoxy-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one

6-Methoxy-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one

C6H6N4O2 (166.0491)


   

1,1,3,3-tetramethyldisiloxane-1,3-diol

1,1,3,3-tetramethyldisiloxane-1,3-diol

C4H14O3Si2 (166.0481)


   

3-methyl-7H-purine-2,6-dione

3-methyl-7H-purine-2,6-dione

C6H6N4O2 (166.0491)


   

1H-1,2,4-Triazole-3-carboxylicacid, 1-(cyanomethyl)-, methyl ester

1H-1,2,4-Triazole-3-carboxylicacid, 1-(cyanomethyl)-, methyl ester

C6H6N4O2 (166.0491)


   

1H-Imidazole-1-aceticacid,4-amino-5-cyano-(9CI)

1H-Imidazole-1-aceticacid,4-amino-5-cyano-(9CI)

C6H6N4O2 (166.0491)


   

trimethyl(methylsulfonylmethyl)silane

trimethyl(methylsulfonylmethyl)silane

C5H14O2SSi (166.0484)


   

1-methyl-1H-pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione

1-methyl-1H-pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione

C6H6N4O2 (166.0491)


   

7,8-Dihydro-2,4(1H,3H)-pteridinedione

7,8-Dihydro-2,4(1H,3H)-pteridinedione

C6H6N4O2 (166.0491)


   

Lyxonic acid

Lyxonic acid

C5H10O6 (166.0477)


   

3-amino-1H-pyrazolo[4,3-c]pyridine-4,6-diol

3-amino-1H-pyrazolo[4,3-c]pyridine-4,6-diol

C6H6N4O2 (166.0491)


   

8-Methyl-9-oxoguanine

8-Methyl-9-oxoguanine

C6H6N4O2 (166.0491)


   

arabic acid

(2S,3R,4R)-2,3,4,5-tetrahydroxypentanoic acid

C5H10O6 (166.0477)


   

2,3,4-Trihydroxy-3-(hydroxymethyl)butanoic acid

2,3,4-Trihydroxy-3-(hydroxymethyl)butanoic acid

C5H10O6 (166.0477)


   

Ribonic acid

D-Ribonic acid

C5H10O6 (166.0477)


The D-enantiomer ribonic acid.

   

L-Xylonic acid

L-Xylonic acid

C5H10O6 (166.0477)


   

L-arabinonic acid

L-arabinonic acid

C5H10O6 (166.0477)


   

L-Lyxonic acid

L-Lyxonic acid

C5H10O6 (166.0477)


A lyxonic acid that has L-configuration.

   

D-lyxonic acid

D-lyxonic acid

C5H10O6 (166.0477)


A lyxonic acid that has D-configuration.

   

S-propyl propanethiosulfinate

S-propyl propanethiosulfinate

C6H14OS2 (166.0486)


A sulfinic acid derivative obtained by formal condensation of propanethiosulfinic acid with propanethiol.

   

3-methyl-9H-xanthine

3-methyl-9H-xanthine

C6H6N4O2 (166.0491)


A 3-methylxanthine tautomer where the imidazole proton is located at the 9-position.

   

3-methyl-7H-xanthine

3-methyl-7H-xanthine

C6H6N4O2 (166.0491)


A 3-methylxanthine tautomer where the imidazole proton is located at the 7-position.

   

1-methyl-7H-xanthine

1-methyl-7H-xanthine

C6H6N4O2 (166.0491)


A 1-methylxanthine tautomer where the imidazole proton is located at the 7-position.

   

D-Ribulose

D-Ribulose

C5H10O6 (166.0477)


   

Arabinonic acid/Xylonic acid

Arabinonic acid/Xylonic acid

C5H10O6 (166.0477)


   

1-{[(s)-propane-1-sulfinyl]sulfanyl}propane

1-{[(s)-propane-1-sulfinyl]sulfanyl}propane

C6H14OS2 (166.0486)